Less than seven weeks after the Food and Drug Administration issued its most serious possible product warning, the Target Up & Up baby wipes lawsuit is rapidly expanding from a single personal injury filing into a multi-front federal litigation with nearly 7 million contaminated packages at its center. Two bacterial strains capable of causing sepsis, pneumonia, and death in newborns were found in wipes marketed as gentle, hypoallergenic, and “99% water” — and evidence is already surfacing that complaints were received before the June 4, 2026 recall was ever issued. If you purchased Up & Up baby wipes or your child was harmed, here is everything you need to know right now.
The June 4, 2026 FDA Class I Recall: What Was Found and Why It Matters
On June 4, 2026, Target Corporation voluntarily recalled two lines of its Up & Up store-brand baby wipes after customer complaints about product discoloration triggered FDA laboratory testing. That testing confirmed the presence of Burkholderia cepacia complex and Burkholderia gladioli — two dangerous bacterial pathogens — in the wipes. The following day, the FDA formally published its recall notice and assigned the action a Class I classification, the agency’s highest risk tier, reserved for situations involving a reasonable probability that use of the product will cause serious adverse health consequences or death.
Burkholderia cepacia complex is particularly dangerous for newborns, infants, and immunocompromised individuals. The bacteria can penetrate the bloodstream through even microscopic breaks in skin — the type of minor skin irritation that diaper rash routinely causes — and produce life-threatening sepsis or pneumonia. For healthy adults, exposure may cause mild or no symptoms. For a two-week-old infant, it can mean an ICU admission. The CDC recognizes Burkholderia cepacia complex as an established cause of severe, difficult-to-treat infections, particularly in vulnerable patient populations.
The affected products were manufactured by Turkish company Sapro Temizlik Urunleri and span two product lines with manufacturing date windows now confirmed by Target’s own recall notice. Families using these wipes on newborns or immunocompromised household members face the highest injury exposure in the Target Up & Up baby wipes lawsuit landscape.
Recall Scope: Affected SKUs, Dates, and Stores
The recall covers packages sold at Target retail locations and Target.com nationwide. Understanding exactly which products are included is essential for any family considering legal action or seeking a refund.
| Product Name | Package Sizes Recalled | Manufacturing Date Range | Distribution |
|---|---|---|---|
| Up & Up Fragrance Free Baby Wipes | 20, 72, 216, 800, 1,200 count | November 7, 2025 – May 5, 2026 | Target stores & Target.com, nationwide |
| Up & Up Fresh Cucumber Scented Baby Wipes | 72, 216, 800 count | December 29–30, 2025 | Target stores & Target.com, nationwide |
| Total Packages Affected | Nearly 7 million packages sold nationally | ||
Families who purchased any of these sizes within these manufacturing windows should stop use immediately, set the product aside in a sealed bag for potential evidence preservation, and document any health symptoms experienced by users — particularly infants or immunocompromised individuals. Discard only after consulting with an attorney if injuries occurred.
The Lawsuits Filed So Far: A Litigation Timeline
June 22, 2026 — First Personal Injury Suit: Baby W.G. and the Goldfin Family
The first lawsuit directly tied to the Target Up & Up baby wipes lawsuit wave was filed June 22, 2026 by prominent food safety firm Marler Clark on behalf of infant W.G., a child from Bucks County, Pennsylvania. According to the filing and reporting by the Philadelphia Inquirer, W.G. was hospitalized in the intensive care unit at Children’s Hospital of Philadelphia after exposure to the contaminated wipes. The Goldfin family’s case is a bellwether personal injury action — the kind that typically establishes the factual and damages framework for broader mass tort litigation. Families in similar situations may want to use a personal injury settlement calculator to begin understanding the potential value of their claims.
July 2, 2026 — First Federal Class Action: Northern District of Illinois
On July 2, 2026, plaintiffs Morgan Finek and Datreoni O’Neal filed the first proposed class action complaint in the U.S. District Court for the Northern District of Illinois against Target Corporation and manufacturer Sapro Temizlik Urunleri. The complaint asserts six causes of action: negligence, unjust enrichment, violations of the Illinois Consumer Fraud and Deceptive Business Practices Act, violations of the Illinois Uniform Deceptive Trade Practices Act, and breach of both express and implied warranties. Crucially, the complaint targets the product’s own marketing language — the wipes were sold as “99% water formula,” hypoallergenic, pediatrician and dermatologist tested, and made with plant-derived ingredients. Plaintiffs argue those representations were deceptive when applied to a product harboring life-threatening bacteria.
July 8, 2026 — Second Federal Class Action: New York
As covered by Law360 on July 8, 2026, a second proposed federal class action was filed in New York, broadening the geographic scope of the litigation. The rapid succession of filings — two class actions in under ten days — signals that the Target Up & Up baby wipes lawsuit is attracting significant plaintiff-side attention nationwide. No Multidistrict Litigation (MDL) consolidation has been formed as of July 22, 2026, which means the litigation remains in its early, most plaintiff-favorable procedural posture. You can review how federal MDL proceedings work through the U.S. Courts system to understand what consolidation could mean for your claim.
The ‘Deliberately Inadequate Recall’ Allegation — A Core Legal Theory
One of the most significant and legally aggressive claims in the Illinois class action is the allegation that Target’s recall was “deliberately designed to preclude the vast majority of consumers” from receiving compensation. The basis: Target’s refund process requires consumers to possess both the physical product and the original purchase receipt. Given that baby wipes are a consumable product routinely discarded before a recall is announced, and receipts are frequently not retained for everyday purchases, plaintiffs argue this creates an intentionally high barrier that effectively nullifies recall relief for most affected families.
This “inadequate recall” theory is not new to mass tort litigation, but it carries particular force here because the pre-recall complaint history is already documented. Attorneys for plaintiffs have alleged that both Target and Sapro had received consumer complaints about skin irritation, eye irritation, and infections before the June 4, 2026 recall was issued. If discovery confirms this timeline, it significantly strengthens claims of negligence and potentially supports punitive damages arguments. Families who suffered serious medical injuries — including sepsis or respiratory illness requiring hospitalization — should explore a wrongful death calculator if a loved one did not survive, as fatal mass tort damages include economic loss, grief, and loss of companionship.
Who Is at Risk: Injury Exposure and Medical Harms
The Target Up & Up baby wipes lawsuit litigation is centered on a product designed for the most vulnerable users imaginable — newborns and infants whose skin barriers are not fully developed and whose immune systems are immature. The injury spectrum ranges from minor skin and eye irritation at the lower end to sepsis, bacterial pneumonia, and death at the highest level of severity. Immunocompromised individuals of any age — including adults with cancer, HIV, organ transplants, or chronic lung conditions like cystic fibrosis — also face elevated risk from Burkholderia cepacia complex exposure.
Medical documentation is the foundation of any viable personal injury claim arising from the Target Up & Up baby wipes lawsuit. Families should gather emergency room records, hospitalization records, pediatrician visit notes, laboratory results identifying bacterial infection, and pharmacy records for any antibiotics or treatment prescribed. If a treating physician can link a Burkholderia infection or unexplained sepsis episode to the timeframe of wipe use, that causal chain becomes central to litigation. Cases involving brain injury from sepsis-related oxygen deprivation in infants may also benefit from a brain injury calculator to assess long-term damages including future care costs.
What Affected Families Should Do Right Now
The Target Up & Up baby wipes lawsuit is still in its earliest stages, with no MDL formed and class certification not yet granted. This is the optimal window for affected families to take protective legal and evidentiary steps. Here is a prioritized action list:
- Stop use immediately of any Up & Up Fragrance Free or Fresh Cucumber Scented baby wipes in your possession.
- Preserve the product — seal remaining wipes in a zip-lock bag, photograph the packaging including lot numbers and manufacturing dates, and store in a cool, dry location.
- Photograph all packaging, including front label, back panel, and any lot/expiration codes before doing anything else.
- Seek medical evaluation for any infant or immunocompromised person who used the wipes, especially if skin irritation, eye infections, fever, or respiratory symptoms occurred.
- Request copies of all medical records from every provider who evaluated or treated the affected person — hospitals, pediatricians, urgent care, and specialists.
- Document your purchase history — check Target Circle account order history, credit card statements, bank records, or app receipts to reconstruct proof of purchase even without a physical receipt.
- Preserve digital communications — any complaints submitted to Target, screenshots of product listings, and confirmations of purchases should be saved and backed up.
- Contact a mass tort attorney experienced in product liability — intake is open at multiple firms and Nolo’s product liability overview can help you understand the legal standard applicable to your claim.
Frequently Asked Questions About the Target Up & Up Baby Wipes Lawsuit
What bacteria were found in the recalled Target Up & Up baby wipes, and how dangerous are they?
The FDA confirmed contamination with two pathogens: Burkholderia cepacia complex and Burkholderia gladioli. Both are gram-negative bacteria capable of causing serious, treatment-resistant infections. In healthy adults, exposure may be inconsequential. In newborns, infants, and immunocompromised individuals, these bacteria can cause sepsis (a life-threatening bloodstream infection), bacterial pneumonia, and death. The FDA assigned the recall its highest risk level — Class I — specifically because the probability of serious harm or death from continued use is considered more than minimal.
Which Target Up & Up baby wipes are included in the recall?
Two product lines are recalled: Up & Up Fragrance Free Baby Wipes in 20, 72, 216, 800, and 1,200 count packages manufactured between November 7, 2025 and May 5, 2026; and Up & Up Fresh Cucumber Scented Baby Wipes in 72, 216, and 800 count packages manufactured December 29–30, 2025. All were sold at Target stores and Target.com nationwide. Nearly 7 million packages were distributed. Consumers who cannot locate lot numbers should check Target.com’s recall page or contact Target customer service to verify their specific product.
Can I still file a lawsuit if I don’t have my receipt or the original product packaging?
Potentially, yes. While Target’s voluntary refund program requires proof of purchase, civil litigation operates under different standards. Attorneys pursuing the Target Up & Up baby wipes lawsuit class actions are specifically challenging the receipt-plus-product requirement as an “inadequate recall” designed to exclude most consumers. Your Target Circle purchase history, credit card or bank statements, and even digital receipts in your email may be sufficient to establish purchase. If your child was harmed, medical records documenting the injury and timeline are often more persuasive than product packaging. Consult a mass tort attorney to assess your specific evidentiary position.
What is the current status of the Target Up & Up baby wipes lawsuits and is there an MDL?
As of July 22, 2026, the Target Up & Up baby wipes lawsuit litigation includes at least one personal injury case (filed June 22, 2026 by Marler Clark in federal court on behalf of infant W.G.) and two proposed federal class actions — one filed July 2, 2026 in the Northern District of Illinois and a second filed July 8, 2026 in New York federal court. No Multidistrict Litigation (MDL) has been formed yet. The absence of MDL consolidation means individual cases and class actions are proceeding independently, and this early stage generally represents a favorable window for new plaintiffs to enter the litigation.
Who are the defendants in the Target Up & Up baby wipes lawsuits and what are the claims?
The named defendants in the class action filings are Target Corporation and Sapro Temizlik Urunleri, the Turkish manufacturer that produced the wipes. Claims asserted in the Illinois federal class action include negligence, unjust enrichment, breach of express and implied warranties, and violations of the Illinois Consumer Fraud and Deceptive Business Practices Act and Illinois Uniform Deceptive Trade Practices Act. The complaints allege that both defendants received consumer complaints of skin irritation and infections before the recall was issued and that the wipes’ “99% water,” hypoallergenic, and pediatrician-tested marketing claims were deceptive given the contamination.
This article is provided for informational purposes only and does not constitute legal advice or create an attorney-client relationship.
Victoria Chambers is a mass tort and class action research analyst with extensive knowledge of multi-district litigation (MDL), defective product cases, dangerous drug lawsuits, and toxic exposure claims across the United States. Victoria is not an attorney and the information provided is for educational purposes only.